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Abstract 
Purpose: To investigate whether paeonol affords neuroprotection against isoflurane-induced 
neurotoxicity.  
Methods: Separate groups of neonatal rat pups were administered paeonol (20, 40 or 80 mg/kg) from 
post-natal day 3 (P3) to post-natal day 15. On post-natal day 7, the pups were exposed to 6 h of 
isoflurane (0.75 %) anesthesia. TUNEL assay was performed to assess neuroapoptosis. Cleaved 
caspase-3 expressions were evaluated by immunohistochemistry and western blotting analysis. The 
expressions of apoptotic pathway proteins and mitogen activated protein kinases (MAPKs) were 
assessed by western blotting. The general behaviour of the rats was determined by open field test and 
elevated maze test. Y-maze test and Morris water maze tests were performed to evaluate working 
memory and cognition.  
Results: Isoflurane exposure caused (p < 0.05) severe neuronal apoptosis in the hippocampal region 
and enhanced caspase-3 expressions. Paeonol supplementation remarkably (p < 0.05) reduced 
neuronal apoptosis and modulated expressions of apoptotic proteins. The raised expressions of NF-κB, 
TNF-α, IL-6 and IL-1β and significantly (p < 0.05) enhanced JNK/p38 signalling cascades were inhibited 
by paeonol. The expression levels of ERK were not significantly (p < 0.05) changed, but there was 
significant improvement in the general behaviour and working memory of the rats.  
Conclusion: Paeonol significantly improves cognitive impairments and offers neuroprotection against 
isoflurane-induced apoptosis via modulating JNK/ERK/p38 MAPK and NF-κB signaling pathways.  
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Increasing number of adults and children are 
exposed to anaesthetics as a part of medical 
care including surgery or related procedures [1]. 
Volatile anesthetics sevoflurane and isoflurane 
are commonly used general anesthetics. 
However, extended exposure to anesthesia can 
cause widespread neurodegeneration in the 
developing brains. Anaethesia-induced with long-
term learning deficits and memory impairments 
have also been reported [2,3]. Recent 
retrospective studies have revealed that children 
exposed to anesthetics during early years are at 
higher risks of cognitive and behavioural 
disabilities [4]. 
 
Previous studies have shown that isoflurane 
causes severe neuroapoptosis in both 
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developing animal brains and primary neuronal 
cells [3]. Neuroinflammation has been reported to 
be involved in volatile anesthetic-induced 
neuroapoptosis and cognitive impairments [5]. 
Isoflurane induces striking increase in 
intracellular calcium levels [Ca2+]i and this 
overload has been found to activate 
mitochondrial apoptotic pathway [6] and also the 
c-Jun N-terminal kinase (JNK) [2].  
 
The ERK, p38 MAPK and JNK are major 
members of mitogen-activated protein kinases 
(MAPK). MAPK cascades critically regulate 
neurogenesis [7], neurodegeneration [8], pain 
and brain inflammation [9] under normal and 
pathological conditions. SP600125, a selective 
JNK inhibitor] was reported to exert 
neuroprotective effects in neurodegenerative 
diseases [10]. Furthermore, it is well known that 
p38 MAPK plays an important role in regulation 
of apoptosis and cell cycle arrest [11]. Thus, 
targeting JNK/ERK/p38 MAPK signalling 
cascades is of immense benefit in preventing 
isoflurane-mediated neuroapoptosis. 
 
Paeonol is a major phenolic compound of the 
genus Paeonia and a key active principle of 
plants such as Paeonia albiflora and Paeonia 
moutan. Paeonol possesses wide range of 
biological properties such as anti-inflammatory 
[12], antitumor [13] and neuroprotective effects 
[14]. Paeonol has been found to prevent 
cardiovascular diseases [15]. . Considering the 
pharmacological potential of paeonol, we 
attempted to investigate if paeonol offered 
protection against isoflurane-induced 
neuroapoptosis and cognitive dysfunctions in 




Chemicals and reagents 
 
Isoflurane (0.75 %) and paeonol were obtained 
from Sigma-Aldrich (St. Louis, MO, USA). 
Antibodies against cleaved caspase-3, Bcl-2, 
Bad, Bcl-xL, Bax, inhibitors of apoptosis proteins 
- xIAP and cIAP-1, survivin and β-actin were 
obtained from Cell Signalling Technology 
(Beverly, MA, USA). JNK, ERK, p38, phospho-
JNK, phospho-ERK, phosphor-p38 and phospho-
c-Jun, NF-κBp65, p-IκBα, TNF-α, IL-1β and IL-6 
(Santa Cruz Biotechnology, Santa Cruz, CA, 
USA) were used for expression analysis. All 
other chemicals and reagents used in this study 
are of analytical grade and were purchased from 




Pregnant Sprague-Dawley rats (Guangdong 
Medical Laboratory Animal Co., China) were 
housed in sterile plastic cages under standard 
housing conditions of 12 h day/night cycle and 
were maintained at 23 ± 2 °C. The rats were 
supplied with water and standard pellet ad 
libidum. The animals were monitored closely for 
the delivery of pups. The day of birth of rat pups 
was noted as post-natal day 0 (P0). The rat pups 
were maintained under the same conditions 
indicated above. The study was approved by the 
University Animal Care Committee (approval no. 
2013034543) and performed in compliance with 
National Institutes of Health Guide for the Use of 




Separate groups of rat pups were administered 
paeonol at 20, 40 or 80 mg/kg body weight from 
P3 to P15 along with standard diet. On P7, pups 
were exposed to 0.75 % isoflurane for 6 h 
(approximately 0.3 MAC in P7 rat pups as 
described by Orliaguet et al [17]) in 30 % oxygen 
or air in a temperature controlled chamber. P7 
rats were chosen based on previous studies 
suggesting that the period is most vulnerable to 
anesthesia-induced neuronal damages. Control 
rats received no anesthesia or paeonol. 
 
Assessment of neuroapoptosis - TUNEL 
fluorescent assay 
 
The influence of paeonol at different 
concentrations (20, 40 or 80 mg) on 
neuroapoptosis induced by isoflurane was 
assessed by TUNEL assay. The rat pups, 
following isoflurane exposure, were perfused 
transcardially with ice-cold saline followed by 4 % 
paraformaldehyde in 0.1 M phosphate buffer. 
The brain tissues were then post-fixed for 48 h at 
4 °C and are embedded in paraffin. The tissues 
were sectioned at 5 µm thickness. The TUNEL 
assay was performed using Dead End TM 
fluorometric TUNEL system kit (Promega, 
Madision, WI, USA). TUNEL positive cells in the 
hippocampal CA1, CA3 and dentate gyrus (DG) 
regions were analyzed with NIS-Elements BR 
image processing and analysis software (Nikon 




To further assess isoflurane-induced neuro-
apoptosis cleaved caspase-3 expression was 
analysed in brain tissues by immunohisto-
chemistry as described previously by Li et al [18]. 
Furthermore, the brain sections were incubated 
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with anti-cleaved caspase-3 primary antibody at 
4 °C overnight following incubation with 
secondary antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) for 40 min. After treatment 
with avidin-biotinylated peroxidase complex 
(Vectostain ABC-Kit, Vector Lab, Burlingame, 
CA, USA) for 40 min, brain tissue sections were 
treated with diaminobenzidine and analyzed with 
NIS-Elements BR image processing and analysis 
software. Extend of apoptosis was determined as 





The expression of apoptotic pathway proteins 
and MAPK proteins in the hippocampi of the rat 
pups were analysed by western blotting. The 
analysis was carried as previously described by 
Li et al [18]. Brain tissues were homogenized in 
ice-cold RIPA buffer (50 mM Tris, pH 7.2; 1 % 
sodium deoxycholate; 150 mM NaCl; 0.1 % 
sodium dodecyl sulfate (SDS); 10 mM NaF; 1 % 
Triton X-100; 1 mM Na3VO4; protease inhibitor 
cocktail (1:1000)]. Homogenates were 
centrifuged at 14,000 rpm for 10 min at 4 °C and 
the supernatants were collected. Protein 
concentration in the tissue samples were 
determined by BCA protein assay (Bio-Rad, 
Hercules, CA, USA). Equal amounts (60 µg) of 
protein samples was subjected to electrophoresis 
on SDS-PAGE and blotted on to polyvinylidene 
difluoride membranes. The membranes were 
incubated with respective primary antibodies at 4 
°C overnight, washed and were further incubated 
with appropriate secondary antibodies. The 
immunoreactive bands were visualized and 
scanned using Image Master II scanner (GE 
Healthcare, Milwaukee, WI, USA). The densities 
of the bands were further analyzed by 
ImageQuant TL software v2003.03 (GE 
Healthcare, Milwaukee, WI, USA). The protein 
expressions were normalized to β-actin. 
 
Memory and learning studies  
 
The effects of paeonol treatment on isoflurane-
induced behavioural changes were assessed by 




Open-field test was performed to assess the 
behavioural response of the rats to a novel 
environment. P32 rats exposed to isoflurane on 
P7 were subjected to open-field test as 
previously described [19]. The behavior of the 
rats in the novel environment was noted as the 
movement of the rats in the open field. The total 
distance travelled (meters) in the test span of 10 
min was recorded. The movement of the rats 
were monitored and analyzed using a 
computerized video tracking system (SMART, 
Barcelona, Spain). 
 
Elevated plus-maze test 
 
In order to evaluate anxiety-related behaviour, 
the elevated plus-maze test was conducted as 
described by Satoh et al [19]. The apparatus 
used for the test consisted of two open (25 x 5 
cm) and two enclosed arms. The arms were 
placed at 50 cm above the floor. The percentage 
of time spent in the open arm by the rats for a 
period of 10 min was noted and this was 
considered as anxiety index. The responses of 
the rats were recorded using the computerized 





The Y-maze test was performed to evaluate the 
spatial working memory. The apparatus 
consisted of a symmetrical Y-maze with three 
arms (25 x 5 cm) separated by 15-cm-high 
transparent walls. The P32 rats exposed to 
isoflurane on P7 were placed at the centre of the 
maze and were allowed to freely explore the 
maze. Each rat was given a time of 8 min to 
explore the maze and the total number of times 
the rats entered the arms and sequence of entry 
were noted. The memory was assessed as 
reported earlier by Kodama et al [20]. 
 
Morris water maze test 
 
The influence of paeonol on isoflurane-induced 
alterations in memory and learning were 
evaluated using Morris water maze (MWM). The 
experiments were performed as described 
previously by Li et al [18]. 
 
P7 rat pups exposed to isoflurane and/or paeonol 
were trained for a period of 4 days between P31 
and P35 in the Morris water maze. A platform of 
about 10 cm in diameter was submerged in a 
circular pool (200 cm diameter, 60 cm depth) 
filled with warm water (23 ± 2 °C). The rats were 
subjected to 2 training sessions/day. The rats 
were allowed to take 60 s to locate the hidden 
platform in the pool and if they failed to locate in 
the given time, they were gently guided. 
Performance of the rats and swim paths were 
monitored and recorded using ANY-maze video 
tracking system (Stoelting Co., Wood Dale, IL, 
USA). The tracking system records and 
measures the time taken (latency) by each rat to 
find the platform. 
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P35 rats were subjected to cued trials to assess 
any visual impairments and/or swimming 
difficulties. The pool was covered by a white 
cloth to hide visual cues. The rats were given 4 
trials/day. During each trial, the rats were placed 
in a specific position of the pool and allowed to 
swim to the platform that had a rod attached. The 
rod served as cue and was placed approximately 
20 cm above water level in any one of the 
quadrants of the pool. Rats were allotted 60 sec 
to locate the submerged platform with the help of 
the rod and about 30 sec time to sit on the 
platform. The rats that were unable to locate the 
platform within 60 sec were gently guided and 
allowed to remain there for 30 sec. The time 





The white cloth used for cued trials was removed 
and same set of rats were assessed for their 
ability to learn and remember the spatial 
relationship between cues and the submerged 
platform (with no cue rod). The platform was 
placed in the same position throughout the place 
trials. The rats were placed at random starting 
points and the time taken to reach the platform 




Probe trials were conducted 24 h after place 
trials to assess memory. The submerged 
platform was removed from the target quadrant 
(the quadrant in which the platform was kept 
throughout the place trials). Rats were allowed to 
swim for 60 sec in the pool and the time that 
each rat spent looking out for the platform in the 
target quadrant was recorded. The time spent by 
the rats in the target quadrant in comparison to 
the time spent in other quadrants was considered 




The results are presented as mean ± standard 
deviation (SD), taken from three or six 
independent experiments and were subjected to 
one-way analysis of variance (ANOVA) and 
Duncan’s Multiple Range Test (DMRT) using 
SPSS statistical package (version 22.0). P < 0.05 




Paeonol reduces isoflurane-induced 
neuroapoptosis 
 
In present study, isoflurane exposure significantly 
(p < 0.05) raised apoptosis in P7 rats. Paeonol 
administration brought marked decrease (p < 
0.05) in apoptotic cell counts in the hippocampal- 
CA1, CA3 and in dendate gyrus (DG) regions. 
The decrease was dose-dependent with 80 mg 
dose exhibiting maximum effects (Figure 1). 
 
Isoflurane increased (p < 0.05) the expression of 
cleaved caspase-3 and it was noticed that 
paeonol markedly (p < 0.05) reduced caspase-3 
expression (Figure 2). Quantification of cleaved 
caspase-3 protein expression by western blots 
also revealed significantly enhanced (p < 0.05) 
expression following isoflurane exposure (Figure 
3). Paeonol at the tested doses (20, 40 and 80 
mg)    significantly    down-regulated    caspase-3 
 
Figure 1: Paeonol inhibits neuroapoptosis induced by isoflurane. Values are presented as mean ± SD, n = 6. a 
represents statistical significance at p < 0.05 compared against control and b-f represents mean values within the 
same group that differ from each other at p < 0.05 as determined by one-way ANOVA followed by DMRT 
analysis 
Zhang et al 
Trop J Pharm Res, October 2016; 15(10): 2177  
 
 
protein expression. This suppression in part 
could have contributed to the decrease in 
apoptotic cell counts. 
 
Paeonol modulates expressions of apoptotic 
pathway proteins  
 
Six hours of isoflurane exposure in P7 rat pups 
caused a robust (p < 0.05) increase in the 
expression of Bax and Bad with decreased 
expression of Bcl-2 and Bcl-xL (Figure 3). 
Administration of paeonol presented significant 
down-regulation of Bax and Bad, while up-
regulating the levels of Bcl-xL and Bcl-2. The 
higher doses of paeonol (40 and 80 mg were 
more effective than 20 mg dose. 
 
 
Figure 2: Influence of paeonol on caspase -3 expressions. Paeonol significantly reduced Isoflurane enhanced 
caspase-3 expressions in a dose-dependent way. Values are represented as mean ± SD, n = 6. a represents 
statistical significance at p < 0.05 compared against control and b-f represents mean values within the same 




Figure 3: Paeonol modulates the expression of 
apoptosis pathway proteins. Isoflurane-induced 
enhanced expressions of proapoptotic proteins were 
down-regulated by paeonol (L1-control; L2-isoflurane; 
L3-isoflurane + 20 mg paeonol; L4-isoflurane + 40 mg 
paeonol; L5-isoflurane + 80 mg paeonol) 
 
Influence of paeonol on the expression of 
proteins of the MAPK signalling pathways 
 
Isoflurane significantly (p < 0.05) enhanced the 
expression of JNK and p38 and as well the 
phosphorylated forms of JNK and p38 MAPK 
(Figure 4). Nevertheless not much increased 
expression of ERK and p-ERK were found 
following isoflurane exposure. On paeonol 
administration, down-regulation of JNK and p38 
was observed along with reduced p-JNK and p-
38 expressions. Pre-treatment with paeonol at 
20, 40 or 80 mg doses failed to cause much 
changes in the expression levels of ERK and p-
ERK compared to the suppression of JNK and 
p38 MAPK. While 20 and 40 mg doses did cause 
down-regulation of p-JNK and p-p38, significant 
results were observed with 80 mg paeonol. 
 
Paeonol significantly regulates the NF-κB 
signalling 
 
Enhanced expression of TNF-α, NF-κBp65, p-
IκBα, IL-1β and IL-6 on isoflurane exposure with 
lowered expression of xIAP, cIAP and survivin 
were observed (Figure 5). Paeonol was found to 
enhance expression of xIAP and cIAP. Paeonol 
significantly down-regulated the NF-κB signalling 
cascades, by effective inhibition of TNF-α, IL-1β 
and IL-6. 
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Figure 4: Paeonol modulates the expression of MAPK 
pathway proteins. Isoflurane enhanced JNK/p-38/ERK 
expressions were significantly down-regulated by 
paeonol (L1-Control; L2-Isoflurane; L3-Isoflurane + 20 
mg paeonol; L4-Isoflurane + 40 mg paeonol; L5-
Isoflurane + 80 mg paeonol) 
 
 
Figure 5: Paeonol modulates NF-κB signalling 
pathway. Paeonol down-regulated isoflurane-induced 
activation of NF-κB mediated inflammatory responses 
(L1-control; L2-isoflurane; L3-isoflurane + 20 mg 
paeonol; L4-isoflurane + 40 mg paeonol; L5-isoflurane 
+ 80 mg paeonol) 
 
Influence of paeonol on behaviour and 
memory of rats following exposure to 
isoflurane  
 
In the open field test, the behaviour of rats in a 
novel environment was observed. Isoflurane 
alone-exposed rats exhibited no noticeable 
behavioural disturbances, however the distance 
they moved across the new open field was 
considerably less than the rats that were treated 
with paeonol and exposed to isoflurane. The rats 
that received paeonol at 40 and 80 mg doses 
exhibited behaviour almost similar to control rats 
that received no paeonol or isoflurane (Figure 
6a). 
 
The elevated maze test revealed that rats 
administered only isoflurane spent considerably 
(p < 0.05) lesser time in the open arms when 
compared to control. Paeonol treatment 
significantly (p < 0.05) improved the behaviour of 
the animals. Paeonol treated rats spent more 
percentage of time in the open arms in the given 
10 min of test time, suggesting improvements in 
the behaviour of animals (Figure 6b). 
 
In order to examine whether isoflurane exposure 
affected the spatial working memory, we 
performed the Y-maze test. The choice and the 
sequence of arms selected by the rats were 
recorded. We observed indifferent behaviour in 
terms of the arms attempted by the rats exposed 
to isoflurane as compared to control rats. 
Paeonol at all the three tested doses was found 
to considerably improve the performance of the 
rats (Figure 6c). 
 
Learning and memory of animals  
 
The time taken by each rat to navigate the pool 
and reach the platform was recorded as escape 
latency. In the present study we found that the 
latency time decreased for all animals with every 
training session irrespective of paeonol 
administration (Figure 7a). However the rats 
administered isoflurane alone exhibited smaller 
variation when compared to animals that 
received paeonol and exposed to isoflurane. 
 
Rats exposed to isoflurane alone were observed 
to take considerably a much longer time to reach 
the submerged platform with the rod (cue) when 
compared to control rats that received no 
anesthesia or paeonol. Nevertheless, the 
animals that received paeonol took significantly 
lesser duration to reach the platform as against 
rats that received isoflurane alone. Also, rats that 
received higher dose of paeonol (80 mg) 
exhibited maximum improvement in performance 
(Figure 7b). Further, place and probe trials were 
conducted to assess the ability of the rats to 
locate and as well remember the location of the 
submerged platform without cue rod. In place 
trials, paeonol-supplemented-rats presented 
improved performance by taking significantly 
lesser time to reach the platform.  
 
Further memory retention was evaluated by 
placing the submerged platform in a random  
 
Zhang et al 
Trop J Pharm Res, October 2016; 15(10): 2179  
 
 
Figure 6: Effect of paeonol on behaviour of rats following exposure to isoflurane on P7. Isoflurane-induced 
memory impairments and cognitive deficits were significantly improved by paeonol. Paeonol at all the tested 
doses markedly enhanced the performance of rats subjected to novel environment (a) elevated maze (b) Y-maze 
test (c) .Values are represented as mean ± SD, n = 6. a represents statistical significance at p < 0.05 compared 
against control and b-f represents mean values within the same group that differ from each other at p < 0.05 as 
determined by one-way ANOVA followed by DMRT analysis 
 
 
Figure 7: Paeonol improved learning and memory of rats exposed to isoflurane on P7. (a) Escape latency of the 
rats exposed to isoflurane. (b) Paeonol effectively improved learning and memory of P35 rats following 
anesthesia exposure on P7 as determined by cued, place and probe trials with Morris Water maze. Values are 
represented as mean ± SD (n = 6); a represents statistical significance at p < 0.05 compared against control and 
b-f represents mean values within the same group that differ from each other at p < 0.05 as determined by one-
way ANOVA followed by DMRT analysis 
 
quadrant other than the target quadrant. Duration 
of time taken to look out for the platform at the 
target quadrant was recorded. 
 
Anesthesia exposure was observed to have a 
significant impact on memory of the rats, as the 
rats exposed to isoflurane spent considerably (p 
< 0.05) lesser time in the target quadrant as 
compared with control group rats that were not 
exposed to anesthesia (Figure 7b). Memory 
retention was found to be improved in paeonol-
treated-rats. The P35 rats administered paeonol 
were observed to spend more time in the target 
quadrant looking out for the platform. Higher 
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doses of paeonol were found to be more 
effective in improving the performance of the rats 
than the lower dose of 20 mg. The observations 
suggest that paeonol was able to significantly 




Isoflurane either alone or combined with other 
drugs is frequently used as general anesthesia in 
children, and adults. Increasing experimental 
data demonstrate that isoflurane induced 
neuronal apoptosis in the developing brains and 
also caused long-term neurocognitive 
dysfunctions [21]. Thus compounds that could 
effectively counter the toxic effects of isoflurane 
without disturbing its anesthetic potential could 
be of great value in medicine. 
 
In line with the previous studies we observed 
robust increase in apoptotic cell counts in the 
hippocampal regions of P7 rats exposed to 6 h of 
isoflurane. Though anesthetic-induced 
neuroapoptosis occurs widely in the brain, we 
focused on the hippocampal region, since 
studies have demonstrated that hippocampal 
neurogenesis is associated with memory 
acquisition [1]. In our study we observed 
remarkable reduction in apoptosis counts in CA1, 
CA3 and DG regions of the pups that were 
supplemented with paeonol. Further 
immunohistochemistry and expression analysis 
revealed significantly enhanced caspase-3 
expressions following exposure to isoflurane. 
Previous studies have demonstrated increased 
activated caspase-3 expressions on isoflurane 
exposure indicating cellular apoptosis [3]. 
Cleaved caspase-3 expression is considered as 
a marker of apoptosis and cell death in 
anesthetic injury [22]. This activation may 
contribute to the structural changes in brain 
tissues [3]. 
 
Enhanced expression of pro-apoptotic proteins – 
Bad and Bax observed after isoflurane treatment 
suggest neuroapoptosis. The balance between 
pro-apoptotic factors and anti-apoptotic factors is 
very critical in cell survival. Paeonol 
administration was found to profoundly bring 
back the balance by effectively improving the 
expressions of Bcl-2 and Bcl-xL while down-
regulating Bad and Bax. Studies have reported 
that Bcl-xL maintains mitochondrial membrane 
integrity and also inhibits cytochrome c release 
thus improving cell survival [23] and suppression 
of apoptosis. In this study activated caspase-3 
expression was also reduced by paeonol. These 
effects potentially could have contributed to the 
decreased apoptotic cell counts observed.  
 
Isoflurane has been reported to induce neuro-
inflammation [5]. More notably, IL-1β is 
associated with isoflurane-induced cognitive 
impairment [5]. Elevated cytosolic Ca2+ levels 
induced by isoflurane has been demonstrated to 
activate the NF-kB signalling pathway [24] that 
stimulates the activation of pro-inflammatory 
cytokines [24]. We observed isoflurane exposure 
resulted in enhanced NF-κBp65, p-Iκ-Bα, TNF-α, 
IL-1 β and IL-6 expressions, in line with previous 
reports [5]. Paeonol at different tested doses 
markedly modulated NF-κB pathway by 
effectively down-regulating NF-κBp65, p-Iκ-Bα, 
TNF-α, IL-1 β and IL-6 suggesting the 
involvement of NF-κB cascades in paeonol 
mediated neuroprotection. 
 
The JNK signalling pathway has been 
documented to be involved in neurodegeneration 
in brain trigged by external stress such as 
ischemia/reperfusion and ethanol [25]. Previous 
studies have demonstrated activation of JNK 
pathway in isoflurane-induced apoptosis [11]. We 
observed strikingly enhanced phosphorylated-
JNK on isoflurane exposure, suggesting 
activated JNK signals which is also supported by 
elevated expressions of p-c-Jun, a JNK target 
protein. Furthermore, activated JNK modulates 
the expressions of Bcl-2 proteins leading to 
apoptosis [25]. Bcl-2/Bcl-xL phosphorylation 
causes change in the mitochondrial membrane 
potential, leading to the release of cytochrome C. 
This subsequently activates caspase-9 and 
caspase-3 leading to apoptosis. Thus paeonol 
mediated suppression of JNK activation critically 
inhibits release of cytochrome C and eventually 
apoptosis.  
 
Furthermore it has been demonstrated that 
isoflurane can activate p38 MAPK [26]. Raised 
levels of p38 and p-p38 were observed in the 
present study, indicating activation of the 
pathway. Studies have shown that p38 MAPK 
signalling cascade exerts crucial roles in 
inflammatory process [26]. Thus the enhanced 
expressions could have also contributed to the 
inflammatory responses observed. Effective 
down-regulation of p-38 and p-p38 expression 
reveals inhibition of p38 signalling on paeonol 
administration. However, although increases in 
the phosphorylated levels of ERK were noticed 
on isoflurane exposure, the elevations were not 
significant as seen in the levels of JNK and p38. 
Paeonol administration did not significantly cause 
any alterations on the activation levels of ERK. 
These observations suggest the involvement of 
JNK and p38MAPKs in isoflurane-induced 
toxicity with negligible involvement of ERK.  
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Accumulating experimental data have raised 
concern over neuronal death and long-term 
cognitive dysfunctions and memory impairments 
induced by anesthetics in young rodent brains 
[1,17]. The observations in the open field test 
indicating improved behaviour on paeonol 
treatment. Working memory is associated in 
holding information temporarily in order to 
perform cognitive tasks that are considerably 
complex. Such tasks involve both hippocampus 
and prefrontal cortex [28]. Y-maze tests indicate 
profound alterations in the working memory on 
isoflurane exposure. Working memory is 
concerned with processes involving 
synchronized temporary storage for performing 
cognitive functions that demand intricate analysis 
and manipulation [28].. These data obtained 
through the behavioural analysis provide 
valuable insight into the effects of neonatal 
anesthesia exposure on cognitive capacities. 
 
Furthermore, paeonol remarkably improved the 
behaviour and memory of the animals. The P35 
rats exhibited a much better performance in Y-
maze tests. Paeonol-mediated reduction in 
hippocampal apoptosis and neuroinflammation 
could have possibly improved the performance.  
 
At P7, rats are extremely sensitive to neurotoxic 
challenge [1] and thus exposure to isoflurane on 
P7 could have severely impaired neurogenesis. 
MWM is the most frequently employed test and 
also is a reliable measure of hippocampus-
dependent spatial navigation and memory 
assessment [22]. The rats were trained to 
explore the swimming pool and reach the 
submerged platform. As expected escape 
latencies of the rats that received isoflurane 
alone was significantly longer than the controls 
that were not exposed to anesthesia. More 
importantly, neuroinflammation also mediates 
isoflurane-induced cognitive impairment [5].  
 
Nevertheless, we observed effective 
improvement in the working memory of the rats 
administered paeonol. At all the given doses, 
paeonol remarkably enhanced the performance 
of rats in MWM tests. The rats also exhibited 
improved memory retention. The results of the 
place, probe and cued trials suggest paeonol 





Significant inhibition of neurodegeneration, 
suppression of NF-κB signalling and marked 
modulation in the JNK/ERK/p38 MAPK pathways 
observed on paeonol treatment probably 
contribute to the improvement in learning and 
memory. Paeonol should therefore be further 
explored for other molecular events which may 
aid in the development of therapies against 
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